ORYZON to Present at The Epigenetics Discovery Congress in London
Oryzon, a clinical stage epigenetic biopharmaceutical company, today announced that it will be presenting at The Epigenetics Discovery Congress to be held at the London Heathrow Marriot Hotel in London on September 24-25.